Alkermes plc. (ALKS) is a Healthcare stock tracked by StreetAlpha. ALKS reports earnings on Wed, Oct 28, 2026. The average 12-month price target from 6 analysts is $56.17, with a high of $65.00 and a low of $37.00. Analyst consensus is Buy, based on the latest ratings from 6 firms (3 buy, 3 hold, 0 sell). Over the past 90 days StreetAlpha recorded 1 whale options trade in ALKS, 0% of them bullish and 100% bearish. In the past 30 days there were 2 dark pool prints totaling $2.6M, the largest $1.6M.
Each firm's latest rating on ALKS in the past 90 days
Average 12-month target
$56.17
Based on 6 analysts who set a price target on ALKS in the past 90 days. The average target is $56.17, with a high of $65.00 and a low of $37.00.
Low $37.00Avg $56.17High $65.00
Highest target$65.00
Average target$56.17
Lowest target$37.00
Latest rating changes
Goldman SachsReinstated
Sep 24Hold$50
BairdTarget raised
Sep 22Buy$58 → $61
HC Wainwright & Co.Reiterated
Aug 16Hold$37
JP MorganTarget raised
Jul 29Hold$60 → $61
BairdMaintained
Jul 29Buy$58
Date
Firm
Action
Rating
Price target
Sep 24
Goldman Sachs
Reinstated
Hold
$50
Sep 22
Baird
Target raised
Buy
$58 → $61
Aug 16
HC Wainwright & Co.
Reiterated
Hold
$37
Jul 29
JP Morgan
Target raised
Hold
$60 → $61
Jul 29
Baird
Maintained
Buy
$58
Loading…
Whale Options Flow
90D
Total alerts
1
Bullish
0
0%
Bearish
1
100%
Date span
Oct 2 – Oct 2
Loading…
Dark Pool
30D
Prints
2
Notional
$2.6M
Largest print
$1.6M
Loading…
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether ALKS is in one of them and how their past ALKS trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
